분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2017-10-14 01:20:21 , Hit : 664
 Advisors to FDA Recommend Approval of Gene Therapy for Blindness

The Scientist »
The Nutshell


http://www.the-scientist.com/?articles.view/articleNo/50623/title/Advisors-to-FDA-Recommend-Approval-of-Gene-Therapy-for-Blindness/&utm_campaign=NEWSLETTER_TS_The-Scientist-Daily_2016&utm_source=hs_email&utm_medium=email&utm_content=57334565&_hsenc=p2ANqtz-_UKkXVdsS3kZ4dscjaPo-FJpNONAY87gv0qmYNW2FwQqK-IElHOva7yGr6-TprrQvboc_oH4Fo81WWeKZPgFs1fXzDaw&_hsmi=57334565



Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

By Jef Akst | October 12, 2017



AddThis Sharing Buttons
Share to FacebookShare to TwitterShare to RedditShare to 이메일Share to 더 보기



gene therapy for blindness
FLICKR, HELGA BIRNA JÓNASDÓTTIR
A panel of 16 independent advisers to the US Food and Drug Administration (FDA) voted unanimously today (October 12) to recommend the approval of Luxturna, a gene therapy meant to treat Leber congenital amaurosis—a rare, inherited form of childhood blindness—and other retinal disorders, STAT News reports. If the agency agrees with the panel’s recommendation, Luxturna would be the first gene therapy aimed at correcting a congenital defect approved in the U.S.

The therapy, developed by Philadelphia-based Spark Therapeutics, is injected directly into the eye in a one-time treatment. Billions of virus particles deliver a functional copy of the RPE65 gene—which encodes a protein necessary for normal vision and is mutated in patients with certain vision disorders—to the retina. So far, more than two dozen children and adults with RPE65 mutations have been treated with Luxturna in the context of clinical trials, and some 93 percent of them have shown improved light sensitivity and functional vision. The effects are long lasting, with improvements continuing for at least four years in some patients that have been tracked that long.

“If my child or myself had this condition I would not hesitate for a moment getting treatment with [Luxturna],” Albert Maguire, a retinal disease specialist at Children’s Hospital of Philadelphia who led the Luxturna clinical trials, said at the advisory panel hearing today, according to STAT News.

If approved, Luxturna would be the first gene therapy that fixes an inherited genetic disorder in the U.S. (The official title of first approved gene therapy goes to Novartis’s CAR T-cell therapy, greenlighted this August.) The FDA must make its decision by January 12, 2018.

“This is what I believe medicine is going to be like for the next 20, 30, if not 50 years,” Spark CEO Jeff Marrazzo tells MIT Technology Review of these types of gene therapies. “I think this is the beginning of an age that is going to fundamentally change medicine.”







1047   CRISPR/Cas9 Edits Epigenome with Therapeutic Efficiency  이성욱 2017/12/09 484
1046   [바이오토픽] 체크포인트 저해제의 부작용: 자가면역질환 초래  이성욱 2017/11/16 686
1045   DNA Repair Mechanism Aids Cancer by Mending Chemo Damage  이성욱 2017/11/10 567
1044   FDA Approves Gilead CAR-T Therapy Yescarta, Plans Regenerative Medicine Policy 'Soon'  이성욱 2017/10/20 607
  Advisors to FDA Recommend Approval of Gene Therapy for Blindness  이성욱 2017/10/14 664
1042   CRISPR System Targets RNA in Mammalian Cells  이성욱 2017/10/06 640
1041   Nonviral CRISPR Delivery a Success  이성욱 2017/10/03 555
1040   Giants of Circadian Biology Win Nobel Prize  이성욱 2017/10/03 499
1039   To Speed CRISPR/Cas9’s Search and Snip, Try Extra Cas9 and gRNA  이성욱 2017/09/30 1988
1038   Technique Adapted from CRISPR-Cas9 Corrects Mutation in Human Embryos  이성욱 2017/09/29 505
1037   Mutations Making CRISPR Hyper-Accurate Discovered  이성욱 2017/09/22 852
1036   CRISPR Used in Human Embryos to Probe Gene Function  이성욱 2017/09/22 582
1035   Alcoholism Gene Therapy Shows Promise  이성욱 2017/09/20 582
1034   DNA Construction  이성욱 2017/09/15 659
1033   Cargo-Sorting DNA Robots  이성욱 2017/09/15 1138
1032   From Startups to Moguls] CRISPR 유전자가위 없이 편집한다? Homology Medicines  이성욱 2017/09/11 603
1031   Outsourcing Gene Editing to the Public-Online Game Challenges Players to Design CRISPR On/Off Switch  이성욱 2017/09/05 722
1030   Scientists Doubt Results of CRISPR’d Embryos  이성욱 2017/09/02 539
1029   Scientists Look to Epigenetics to Thwart Viruses  이성욱 2017/09/02 709
1028   First CAR T-Cell Therapy Approved in U.S.  이성욱 2017/09/01 689

[이전 10개] [1]..[11] 12 [13][14][15][16][17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN